Skip to Content
MilliporeSigma
  • Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors.

Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors.

JCI insight (2019-11-15)
Katja Pekrun, Gustavo De Alencastro, Qing-Jun Luo, Jun Liu, Youngjin Kim, Sean Nygaard, Feorillo Galivo, Feijie Zhang, Ren Song, Matthew R Tiffany, Jianpeng Xu, Matthias Hebrok, Markus Grompe, Mark A Kay
ABSTRACT

While gene transfer using recombinant adeno-associated viral (rAAV) vectors has shown success in some clinical trials, there remain many tissues that are not well transduced. Because of the recent success in reprogramming islet-derived cells into functional β cells in animal models, we constructed 2 highly complex barcoded replication competent capsid shuffled libraries and selected for high-transducing variants on primary human islets. We describe the generation of a chimeric AAV capsid (AAV-KP1) that facilitates transduction of primary human islet cells and human embryonic stem cell-derived β cells with up to 10-fold higher efficiency compared with previously studied best-in-class AAV vectors. Remarkably, this chimeric capsid also enabled transduction of both mouse and human hepatocytes at very high levels in a humanized chimeric mouse model, thus providing a versatile vector that has the potential to be used in both preclinical testing and human clinical trials for liver-based diseases and diabetes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Phospho-L-ascorbic acid trisodium salt, ≥95.0% (HPLC)
Sigma-Aldrich
Zinc sulfate heptahydrate, BioReagent, suitable for cell culture
Sigma-Aldrich
Arachidonoyl dopamine, ≥98% (HPLC), ethanol solution
Sigma-Aldrich
Nicotinamide, ≥98% (HPLC), powder
Sigma-Aldrich
Fetal Bovine Serum, USA origin, sterile-filtered, suitable for cell culture, suitable for hybridoma